KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gsk (GSK) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for Gsk (GSK) over the last 17 years, with Q3 2025 value amounting to -$1.4 billion.

  • Gsk's Other Non-Current Liabilities fell 183.21% to -$1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.4 billion, marking a year-over-year decrease of 183.21%. This contributed to the annual value of -$1.4 billion for FY2024, which is 20212.0% down from last year.
  • Latest data reveals that Gsk reported Other Non-Current Liabilities of -$1.4 billion as of Q3 2025, which was down 183.21% from -$1.3 billion recorded in Q2 2025.
  • In the past 5 years, Gsk's Other Non-Current Liabilities registered a high of $1.4 billion during Q4 2023, and its lowest value of -$1.4 billion during Q2 2024.
  • In the last 5 years, Gsk's Other Non-Current Liabilities had a median value of -$1.1 billion in 2023 and averaged -$790.6 million.
  • In the last 5 years, Gsk's Other Non-Current Liabilities soared by 9925.53% in 2022 and then plummeted by 1336705.6% in 2023.
  • Over the past 5 years, Gsk's Other Non-Current Liabilities (Quarter) stood at $1.2 billion in 2021, then decreased by 15.07% to $1.1 billion in 2022, then soared by 30.3% to $1.4 billion in 2023, then tumbled by 202.76% to -$1.4 billion in 2024, then rose by 2.54% to -$1.4 billion in 2025.
  • Its Other Non-Current Liabilities stands at -$1.4 billion for Q3 2025, versus -$1.3 billion for Q2 2025 and -$1.3 billion for Q1 2025.